Phase 2a Randomized Placebo-Controlled Human Challenge Trial of the RSV L-Protein Inhibitor S-337395 for Respiratory Syncytial Virus Infection. (academic.oup.com)

Authors: Byrne S … Uehara T Journal: Clinical Infectious Diseases Published: 2026-06-15 DOI: https://doi.org/10.1093/cid/ciag367